Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Capecitabine (Primary) ; Indibulin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 18 Jul 2012 Planned End Date changed from 1 Dec 2008 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 18 Jul 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Jul 2009 Planned end date changed from 1 Dec 2008 to 1 Feb 2009.